Related Experiment Video
Updated: Jul 2, 2025
09:08
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
5.5K
Small cell lung cancer with dermatomyositis: a case report
Xiaomin Guan1, Shi Qiu1, Yinghui Xu1
1Cancer Center, The First Hospital of Jilin University, Changchun, Jilin, China.
Frontiers in Oncology
|February 28, 2024
Summary
Dermatomyositis, an autoimmune disease, can be linked to cancer. Treating the underlying small cell lung cancer improved the patient's dermatomyositis symptoms, highlighting the importance of cancer screening.
Area of Science:
- Autoimmune diseases
- Oncology
- Dermatology
Background:
- Dermatomyositis is an autoimmune disorder with skin and muscle symptoms.
- Malignancy is a known risk factor for dermatomyositis.
- Hormone therapy is often suboptimal for malignancy-associated dermatomyositis.
Observation:
- A 60-year-old male with dermatomyositis resistant to hormone therapy was diagnosed with small cell lung cancer.
- Dermatomyositis was suspected as a paraneoplastic syndrome.
- Cancer treatment led to dermatomyositis symptom improvement.
Findings:
- Successful treatment of small cell lung cancer with chemotherapy and radiotherapy resulted in partial remission.
- Dermatomyositis symptoms significantly improved as the cancer regressed.
- Hormone dosage for dermatomyositis could be gradually reduced.
Implications:
- This case highlights the critical link between dermatomyositis and underlying malignancy.
- Effective tumor treatment can ameliorate paraneoplastic dermatomyositis.
- Routine cancer screening is essential for dermatomyositis patients.
